Market Dashboard
SRIT India Logo

SRIT India

Listed
MainboardBook build Issue
Issue Price
₹123 to ₹130 Per Share
Face Value
₹5 Per Equity Share
Issue Size
Approx ₹218.40 Crores
Listing On
BSENSE
Live

Allotment Available

Check your individual allotment on the official registrar portal.

Check Allotment

Grey Market

₹53
+40.77% Est. Listing Premium
Est. Listing Price₹183
Updated: 03 Oct 2026, 10:44

About SRIT India IPO

SRIT India, founded in September 1999, is an IT and IT-enabled Services (IT/ITeS) solutions firm that offers digital solutions, custom application development, and system integration services. The firm has over 26 years of experience in designing, implementing, and operating digital platforms for government entities and organizations in India as well as international markets.

Financial Health

Period EndedRevenuePATAssets
2024₹282.22₹29.08₹428.96
2025₹400.50₹33.60₹496.64
2026₹462.54₹43.29₹614.16

Live Subscriptions

Tracking

Detailed subscription data will populate once bidding opens.

Frequently Asked Questions

The public subscription window officially opens on 28 September 2026 and concludes at 5:00 PM IST on 30 September 2026.
As of the latest market information, the GMP is ₹53, indicating a 40.77% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹123 to ₹130 Per Share. Retail investors must bid for at least 115 shares, requiring a block investment of ₹14,950.
The allotment has been detected as available in the Kfin Technologies Ltd. system. You can use the official registrar link on this page to check your individual status. Shares are scheduled to debut on the exchanges on 06 October 2026.
The registrar for this IPO is Kfin Technologies Ltd..
The issue size for SRIT India is Approx ₹218.40 Crores.
The current status of the SRIT India IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.